Lachey Jennifer 4
4 · Keros Therapeutics, Inc. · Filed Jul 15, 2022
Insider Transaction Report
Form 4
Lachey Jennifer
Chief Scientific Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-07-13−1,916→ 54,789 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (1,916 underlying) - Sale
Common Stock
2022-07-13$30.00/sh−1,916$57,480→ 95,100 total - Exercise/Conversion
Common Stock
2022-07-13$0.30/sh+1,916$575→ 93,184 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Immediately exercisable.